The DOI matches its Crossref record; 180 of the 184 references it cites were found in a registry or an index, and 4 are not checked yet.
Artificial Mitochondria Transfer: Current Challenges, Advances, and Future Applications
Open accessAbstract
The objective of this review is to outline existing artificial mitochondria transfer techniques and to describe the future steps necessary to develop new therapeutic applications in medicine. Inspired by the symbiotic origin of mitochondria and by the cell’s capacity to transfer these organelles to damaged neighbors, many researchers have developed procedures to artificially transfer mitochondria from one cell to another. The techniques currently in use today range from simple coincubations of isolated mitochondria and recipient cells to the use of physical approaches to induce integration. These methods mimic natural mitochondria transfer. In order to use mitochondrial transfer in medicine, we must answer key questions about how to replicate aspects of natural transport processes to improve current artificial transfer methods. Another priority is to determine the optimum quantity and cell/tissue source of the mitochondria in order to induce cell reprogramming or tissue repair, in both in vitro and in vivo applications. Additionally, it is important that the field explores how artificial mitochondria transfer techniques can be used to treat different diseases and how to navigate the ethical issues in such procedures. Without a doubt, mitochondria are more than mere cell power plants, as we continue to discover their potential to be used in medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Natural mitochondria transfer. Viable and nonfunctional mitochondria can be shared by the cell inducing different cellular responses from cellular rescue to promoting inflammation. The first transfer mechanism is the microvesicle transport of mitochondria, it has been observed specially in MSCs in which the secreted microvesicles carrying mitochondria, once internalized by the recipient cells, induce its rescue from cellular damage and enhance the phagocytic properties of immune cells [182, 183]. The second way of transfer is by TNTs; many cells share the ability to produce them and transport mitochondria with proven effects in the rescue from cellular damage, metabolic reprogramming, and immune enhancement and it was also associated with its differentiation [65, 184]. During cellular stress, defective mitochondria can be released without being covered like in apoptotic or mitoapoptotic bodies and being naked promoting the immune response and inflammation [17, 77, 185].](/paper-figures/9dd4535e40bf4f7bb2ff1261ae1b586e/artificial-mitochondria-transfer-current-challenges-advances-and-future-figure-1.jpg)
![Figure 2 Artificial mitochondria transfer (AMT) and transplant. Different techniques emerged to mimic the natural transfer or mitochondria on its in vivo and in vitro applications. The coincubation technique was the first proposed in which the antibiotic resistance carried in the mitochondrial DNA was passed to sensitive cells [9], later after the technique was used to rescue respiratory deficient cells among other damaged cells [10, 11, 14, 63]. Microinjection of exogenous mitochondria was applied in assays to eliminate the endogenous copies of oocytes carrying mitochondrial diseases [90, 93]. The photothermal nanoblade effectively transferred isolated mitochondria inside the cell; even if they showed great effectiveness, its application is limited to small cell numbers [12]. Two different approaches were developed to facilitate the mitochondria internalization in the recipient cells, the first is by using Pep-1 and the other with magnetic beads (Magnetomitotransfer) designed to bind to TOM22 a receptor complex in the mitochondrial membrane. The MitoCeption technique uses a thermic shock and a centrifugation to improve the process of mitochondria uptake; first applied in cancer cells, this technique induces the metabolic reprogramming of these cells. The in vivo application of the mitochondria transfer applies two approaches: the first is to directly inject mitochondria to the harmed tissue and the other in the circulatory system close to the area of interest. Both of them have shown to restore tissue function but the in situ injection showed better results [16, 49, 50].](/paper-figures/3838f6b4d83348649f0b1b2195e4812f/artificial-mitochondria-transfer-current-challenges-advances-and-future-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Assessing the presence of extracellular mitochondria or their fragments by measuring ccf-mtDNA levels could allow on-flight direct estimation of cellular stress to take preventive measures of cumulative damage196,199–206.”
From Key points for the development of antioxidant cocktails to prevent cellular stress and damage caused by reactive oxygen species (ROS) during manned space missions (2021) · cites this paper as [200]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Kocher, T. D., Thomas, W. K., Meyer, A., Edwards, S. V., Pääbo, S., Villablanca, F. X., & Wilson, A. C. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6196 · Cited by 4,964
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy
Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M. S., Elsas, L. J., & Nikoskelainen, E. K. (1988) · Science · doi:10.1126/science.3201231 · Cited by 2,440
Regulation of immune responses by extracellular vesicles
Robbins, P. D., & Morelli, A. E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3622 · Cited by 2,260
Nanotubular Highways for Intercellular Organelle Transport
Rustom, A., Saffrich, R., Markovic, I., Walther, P., & Gerdes, H.-H. (2004) · Science · doi:10.1126/science.1093133 · Cited by 2,038
Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies
Holt, I. J., Harding, A. E., & MORGAN-HUGHES, J. A. (1988) · Nature · doi:10.1038/331717a0 · Cited by 1,860
Research works printed but not linked: 9
- 2016, Scientific Reports, 6, article 26057
- 2016, Biofabrication, 8
- 2014, Frontiers in Physiology, 5, 400
- 2016, Gastroenterology and Hepatology from Bed to Bench, 9, 105
- 2017, Biochimica et Biophysica Acta (BBA)-Bioenergetics
- 2017, Stem Cells International, 2017
- 2016, Nippon Ganka Gakkai Zasshi, 120, 210
- 2016, American Journal of Stem Cells, 5, 39
- 2015, Diabetologia, 59, 325
Cited by
Sorted by citations
Intercellular mitochondrial transfer as a means of tissue revitalization
Liu, D., Gao, Y., Liu, J., Huang, Y., Yin, J., Feng, Y., Shi, L., Meloni, B. P., Zhang, C., Zheng, M., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00440-z · Cited by 403
Regenerative abilities of mesenchymal stem cells through mitochondrial transfer
Paliwal, S., Chaudhuri, R., Agrawal, A., & Mohanty, S. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0429-1 · Cited by 343
Mitochondrial transfer/transplantation: an emerging therapeutic approach for multiple diseases
Liu, Z., Sun, Y., Qi, Z., Cao, L., & Ding, S. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00805-7 · Cited by 236
Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment
Ubaldi, F. M., Cimadomo, D., Vaiarelli, A., Fabozzi, G., Venturella, R., Maggiulli, R., Mazzilli, R., Ferrero, S., Palagiano, A., & Rienzi, L. F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00094 · Cited by 220
Bustamante-Barrientos, F. A., Luque‐Campos, N., Araya, M. J., Lara-Barba, E., Solminihac, J. D., Pradenas, C., Molina, L., Herrera-Luna, Y., Utreras‐Mendoza, Y., Elizondo-Vega, R. J., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04493-w · Cited by 204
Metadata
- Authors
- Caicedo, A., Aponte, P. M., Cabrera, F., Hidalgo, C., & Khoury, M.
- Affiliations
- Universidad San Francisco de Quito (EC)
- Inserm (FR)
- Universidad de Los Andes, Chile (CL)
- Corresponding author
- Caicedo, Andrés
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-23
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- PMC
- PMC5511681
- OpenAlex
- W2724908046
- Cited by
- 150
- References
- 180
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 22 · 2023: 27 · 2022: 21 · 2021: 22 · 2020: 20 · 2019: 9 · 2018: 4
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Stem Cells International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Funders
- Chilean FONDECYT (1170852)
- USFQ Publication Fund (1170852)
- USFQ Medical School (1170852)
- USFQ Chancellor (1170852)
- USFQ Collaboration (1170852)
- Universidad San Francisco (1170852)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- mitochondrial transfer, mitochondrial biogenesis, cellular reprogramming, tissue repair, mitochondrial transport, therapeutic applications, ethical considerations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review